Japan announces the start of supplying a possible free coronavirus drug to 43 countries, including Arab countries



[ad_1]

Japan announces the start of supplying a possible free coronavirus drug to 43 countries, including Arab countries

Reuters

Issei Kato

Pills of the drug “Afghan”, also known as “faviravir” and “favelavir”.

Japan announced that it will begin importing the drug “Afghan”, also known as “faviravir” and “favelaver,” free of charge to 43 countries for treatment of Corona virus infection next week.

Read more

Russia intends to introduce a batch of antiretroviral medicine test to its market next week

Japan’s Foreign Minister Tosimitsu Motegi said at a press conference on Friday, “It was revealed during telephone conversations with foreign ministers from all countries that there is great interest in Afghans.” Supply details with 43 countries “.

Motegi added that the start of supply operations will be shortly after the holidays, after the days of the “Golden Week”, that is, before May 6.

The Japanese Foreign Minister explained that the talk is currently on the stage of clinical trials and for this reason, sufficient batches of drugs will be provided to treat between 20 and 100 people in each country.

He highlighted his country’s intention to cooperate with the private sector and the international community to develop a way to treat the Corona virus.

The group of countries to which this medicine will be supplied includes 6 countries in the Middle East, including Kuwait and Qatar.

“Avigan” was designed in Japan to treat the flu and received a formal license to sell it in 2014, but later tests on animals monitored for side effects reflected in the condition of the fetus, leading to the exclusion of drug use. in pregnant women, while it was included in the drug list. That can only be approved with special permission from the government.

During the outbreak of the new Corona virus in China since late 2019, Chinese scientists discovered that “Afghan” is effective in treating pneumonia caused by “COVID-19” infection.

Source: Japanese media + Novosti



[ad_2]